Folgen
Frederik Barkhof
Frederik Barkhof
VU University Medical Center
Bestätigte E-Mail-Adresse bei vumc.nl - Startseite
Titel
Zitiert von
Zitiert von
Jahr
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
AJ Thompson, BL Banwell, F Barkhof, WM Carroll, T Coetzee, G Comi, ...
The Lancet Neurology 17 (2), 162-173, 2018
69332018
Consistent resting-state networks across healthy subjects
JS Damoiseaux, SARB Rombouts, F Barkhof, P Scheltens, CJ Stam, ...
Proceedings of the national academy of sciences 103 (37), 13848-13853, 2006
50152006
Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration
JM Wardlaw, EE Smith, GJ Biessels, C Cordonnier, F Fazekas, R Frayne, ...
The Lancet Neurology 12 (8), 822-838, 2013
47642013
Defining the clinical course of multiple sclerosis: the 2013 revisions
FD Lublin, SC Reingold, JA Cohen, GR Cutter, PS Sørensen, ...
Neurology 83 (3), 278-286, 2014
38072014
Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis
JA Cohen, F Barkhof, G Comi, HP Hartung, BO Khatri, X Montalban, ...
New England Journal of Medicine 362 (5), 402-415, 2010
28242010
A new rating scale for age-related white matter changes applicable to MRI and CT
LO Wahlund, F Barkhof, F Fazekas, L Bronge, M Augustin, M Sjogren, ...
Stroke 32 (6), 1318-1322, 2001
20902001
Atrophy of medial temporal lobes on MRI in" probable" Alzheimer's disease and normal ageing: diagnostic value and neuropsychological correlates.
P Scheltens, D Leys, F Barkhof, D Huglo, HC Weinstein, P Vermersch, ...
Journal of Neurology, Neurosurgery & Psychiatry 55 (10), 967-972, 1992
19551992
Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis.
F Barkhof, M Filippi, DH Miller, P Scheltens, A Campi, CH Polman, ...
Brain: a journal of neurology 120 (11), 2059-2069, 1997
18001997
Effect of early interferon treatment on conversion to definite multiple sclerosis: a randomised study
G Comi, M Filippi, F Barkhof, L Durelli, G Edan, O Fernández, HP Hartung, ...
The Lancet 357 (9268), 1576-1582, 2001
14842001
Reduced resting-state brain activity in the “default network” in normal aging
JS Damoiseaux, CF Beckmann, EJS Arigita, F Barkhof, P Scheltens, ...
Cerebral cortex 18 (8), 1856-1864, 2008
14282008
A semiquantative rating scale for the assessment of signal hyperintensities on magnetic resonance imaging
P Scheltens, F Barkhof, D Leys, JP Pruvo, JJP Nauta, P Vermersch, ...
Journal of the neurological sciences 114 (1), 7-12, 1993
11241993
MRI criteria for the diagnosis of multiple sclerosis: MAGNIMS consensus guidelines
M Filippi, MA Rocca, O Ciccarelli, N De Stefano, N Evangelou, L Kappos, ...
The Lancet Neurology 15 (3), 292-303, 2016
10512016
Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromes
L Kappos, CH Polman, MS Freedman, G Edan, HP Hartung, DH Miller, ...
Neurology 67 (7), 1242-1249, 2006
10232006
Cortical lesions in multiple sclerosis
D Kidd, F Barkhof, R McConnell, PR Algra, IV Allen, T Revesz
Brain 122 (1), 17-26, 1999
9661999
STandards for ReportIng Vascular changes on nEuroimaging (STRIVE v1). Neuroimaging standards for research into small vessel disease and its contribution to ageing and …
JM Wardlaw, EE Smith, GJ Biessels, C Cordonnier, F Fazekas, R Frayne, ...
Lancet Neurol 12 (8), 822-838, 2013
9632013
Evaluation of patients treated with natalizumab for progressive multifocal leukoencephalopathy
TA Yousry, EO Major, C Ryschkewitsch, G Fahle, S Fischer, J Hou, ...
New England Journal of Medicine 354 (9), 924-933, 2006
9562006
Clinically isolated syndromes suggestive of multiple sclerosis, part I: natural history, pathogenesis, diagnosis, and prognosis
D Miller, F Barkhof, X Montalban, A Thompson, M Filippi
The Lancet Neurology 4 (5), 281-288, 2005
9532005
Ocrelizumab in relapsing-remitting multiple sclerosis: a phase 2, randomised, placebo-controlled, multicentre trial
L Kappos, D Li, PA Calabresi, P O'Connor, A Bar-Or, F Barkhof, M Yin, ...
The Lancet 378 (9805), 1779-1787, 2011
9432011
Altered resting state networks in mild cognitive impairment and mild Alzheimer's disease: an fMRI study
SARB Rombouts, F Barkhof, R Goekoop, CJ Stam, P Scheltens
Human brain mapping 26 (4), 231-239, 2005
9182005
The clinico-radiological paradox in multiple sclerosis revisited
F Barkhof
Current opinion in neurology 15 (3), 239-245, 2002
8992002
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20